Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

To learn whether an eating pattern called intermittent fasting (IF) is tolerable and feasible for individuals at high risk of pancreatic cancer and whether IF is associated with changes in biological markers, including metabolic, inflammatory, microbiome, and imaging-related markers.

Trial Details

NCT ID
NCT07513116
Phase
NA
Sponsor
M.D. Anderson Cancer Center
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • intermittent fasting
Locations (sample)
  • Houston, Texas, United States|29.76328,-95.36327

Key Eligibility Criteria

  • Participants ≥ 18 years old. Participants under 18 are excluded due to their potential inability to understand and consent independently to the met…
  • Participants evaluated and classified as high risk for pancreatic cancer through a High-Risk Pancreatic Cancer Clinic or High-Risk Pancreatic Cyst …
  • High-risk status may include one or more of the following:
  • Hereditary cancer syndromes or known pathogenic germline mutations associated with pancreatic cancer risk

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →